Developer of therapeutics designed to treat fibrotic diseases. The company develops a drug discovery platform to regulate the monocyte-derived cell populations that play roles in fibrotic, inflammatory and autoimmune diseases, enabling patients with medicines to cure their diseases.

Register for Details

For more details on financing and valuation for Promedior, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Promedior

Forge green plus iconForge green minus icon

What is Promedior funding to date?

Promedior has raised $76MM to date.
Forge green plus iconForge green minus icon

When was Promedior founded?

Promedior was founded in 2006.
Updated on: Jun 12, 2022